Gao R, Liang W, Chen J, Yang M, et al. Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA adverse event reporting system. BMC Cancer 2025;25:216.
PMID: 39920614